0000885590-11-000017.txt : 20110411
0000885590-11-000017.hdr.sgml : 20110408
20110411152025
ACCESSION NUMBER: 0000885590-11-000017
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20100928
FILED AS OF DATE: 20110411
DATE AS OF CHANGE: 20110411
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Provencio Norma Ann
CENTRAL INDEX KEY: 0001343811
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 11752590
MAIL ADDRESS:
STREET 1: 1041 WEST BADILLO STEET, SUITE 112
CITY: COVINA, CA
STATE: CA
ZIP: 91722
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7150 MISSISSAUGA ROAD
STREET 2: MISSISSAUGA
CITY: ONTARIO
STATE: A6
ZIP: 00000
BUSINESS PHONE: 905 286-3000
MAIL ADDRESS:
STREET 1: 7150 MISSISSAUGA ROAD
STREET 2: MISSISSAUGA
CITY: ONTARIO
STATE: A6
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4/A
1
primary_doc.xml
PRIMARY DOCUMENT
X0303
4/A
2010-09-28
2010-09-30
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001343811
Provencio Norma Ann
C/O 7150 MISSISSAUGA ROAD
MISSISSAUGA
A6
L5N 8M5
ONTARIO, CANADA
1
0
0
0
Common Stock, no par value
2010-09-28
4
A
0
98930
0
A
98930
D
Common Stock, no par value
2010-09-28
4
A
0
9051
0
A
107981
D
Common Stock, no par value
2010-09-28
4
A
0
28795
0
A
136776
D
Common Stock, no par value
2010-09-28
4
A
0
6233
0
A
143009
D
Represents restricted share units received upon conversion of a portion of the reporting person's Valeant Pharmaceuticals International ("old Valeant") restricted stock units that were held prior to the merger between the issuer (formerly known as Biovail Corporation) and old Valeant (the "Merger"), in accordance with the terms of the merger agreement between the issuer and, amongst others, old Valeant. The restricted share units can be settled only in common shares of the issuer. The fair market value of old Valeant on the day prior to the effective date of the Merger was $63.25 per share.
Represents common shares received upon conversion of the reporting person's remaining old Valeant restricted stock units that were held prior to the Merger (i.e. those that were not converted into restricted share units as described in Footnote 1), in accordance with the terms of the merger agreement. The fair market value of old Valeant on the day prior to the effective date of the Merger was $63.25 per share.
Represents common shares held in the reporting person's 401k account and received in the Merger upon conversion of the reporting person's old Valeant common shares.
This amendment is being filed to correct the number of common shares that were reported in the original filing.
Represents common shares held in the reporting person's IRA and received in the Merger upon conversion of the reporting person's old Valeant common shares.
By: Angie Palmer for Norma A. Provencio
2010-04-11